{"name":"Avelos Therapeutics Inc.","slug":"avelos-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AD1208","genericName":"AD1208","slug":"ad1208","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AD1208","genericName":"AD1208","slug":"ad1208","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE40ZV96UmN5WWItN3NndTE5RFFjVms2RUFSVjljZG5PSWlnWXItRm1pVWJETjNkNDByT1d5WEt0YnhUVzhrU0h1N3B0cnhpZXAyOHE2Q1BldHFlQVptNzBTeEdUNGtxYkpzRmJwdNIBcEFVX3lxTE9WRjd0OFREOXE2Z1Z1dWtjRGtWUWJFU0I5emhSRUhNOWE1c21wa3JFWVVERWpoZFlkUUZYbTktS2s4MlFZcHNySUYzcVAxM3RKNXZPbWhyRHBKRGRpX18ycU1tSXdxNk9hQlBLTlFtWWU?oc=5","date":"2025-06-04","type":"trial","source":"thebionews.net","summary":"Avelos unveils secret weapon 'Twin-headed carriage' data, CEO Choi Soon-gyu: \"Priority on technology transfer\" - thebionews.net","headline":"Avelos unveils secret weapon 'Twin-headed carriage' data, CEO Choi Soon-gyu: \"Priority on technology transfer\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQMmM0a0lNWklWSkNjSnF6dTNWZ2hLRkVteXNXUVRmMHZDZzFSWFdab3UzZGpUdVFHY2ZrMURFeERfOU1CdTZ4QWc3MDhZOHcxeXBsLXB1Z0RsZ2RMck5rZ1VXODNCZ0I3cjZRNENSNXNhdF93TWpQalVEd1lXZHUyRmNSX0JkQ0lDa2s1OEVFNU5LZnBEbkcyNA?oc=5","date":"2023-02-07","type":"pipeline","source":"BioSpectrum Asia","summary":"Cancer Therapeutics Gaining Ground in APAC - BioSpectrum Asia","headline":"Cancer Therapeutics Gaining Ground in APAC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPd09kZ2NVdnhmOFJVeDBYLXJOZ2Z1Ny03N2pLSEt6STZTempMdHdJb0FJT0pfVUhNYml1QWNJUk5uT0t4Z3lNeVhObDFseG1RWTU3eXZrSzdwUFFMMTZRX3lXQnB1Q1dTS0FHMHRsU2RKd2ZGdktlSXphWjFTNnFwbkZBOFZvNXNwVmZVdTlaNGppMy1h?oc=5","date":"2023-01-04","type":"pipeline","source":"BioWorld News","summary":"Avelos Therapeutics presents new MASTL inhibitors - BioWorld News","headline":"Avelos Therapeutics presents new MASTL inhibitors","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}